Question · asked by 1 review
Intranasal steroid spray vs placebo or no intervention: Disease‐related quality of life
- Population
- people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection
- Intervention
- Intranasal steroid spray
- Comparison
- placebo or no intervention
- Outcome
- Disease‐related quality of life
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Intranasal steroid spray vs no intervention/placebo Disease‐related quality of life · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection The review found no eligible studies for this question. Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction (2022) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction 2022 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Intranasal steroid spray vs no intervention · people with olfactory dysfunction for less than 4 weeks following COVID‐19 infection · 0 reviews
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.